Cartesian Therapeutics Q2 EPS $0.50 Compared With $0.54 YoY, Sales Total $298.000K

Cartesian Therapeutics (NASDAQ: RNAC) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $(0.82) by 160.98 percent. This is a 7.41 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $298.000 thousand which missed the analyst consensus estimate of $771.429 thousand by 61.37 percent. This is a 99.11 percent decrease over sales of $33.445 million the same period last year.